Annual SG&A
$116.81 M
+$29.01 M+33.04%
31 December 2023
Summary:
Beam Therapeutics annual selling, general & administrative expenses is currently $116.81 million, with the most recent change of +$29.01 million (+33.04%) on 31 December 2023. During the last 3 years, it has risen by +$87.21 million (+294.57%). BEAM annual SG&A is now at all-time high.BEAM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$26.52 M
-$3.11 M-10.50%
30 September 2024
Summary:
Beam Therapeutics quarterly selling, general & administrative expenses is currently $26.52 million, with the most recent change of -$3.11 million (-10.50%) on 30 September 2024. Over the past year, it has increased by +$1.10 million (+4.35%). BEAM quarterly SG&A is now -38.70% below its all-time high of $43.26 million, reached on 31 December 2023.BEAM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$5.33 B
-$143.59 M-2.77%
30 September 2024
Summary:
Beam Therapeutics TTM selling, general & administrative expenses is currently -$5.33 billion, with the most recent change of -$143.59 million (-2.77%) on 30 September 2024. Over the past year, it has dropped by -$5.43 billion (-5642.91%). BEAM TTM SG&A is now -4177.12% below its all-time high of $126.12 million, reached on 30 September 2024.BEAM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.0% | +4.3% | -5642.9% |
| 3 y3 years | +294.6% | +68.1% | -10000.0% |
| 5 y5 years | +884.3% | +383.2% | -10000.0% |
BEAM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +294.6% | -38.7% | +68.1% | -124.5% | at low |
| 5 y | 5 years | at high | +884.3% | -38.7% | +383.2% | -1069.5% | at low |
| alltime | all time | at high | +884.3% | -38.7% | +835.6% | -4177.1% | at low |
Beam Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $26.52 M(-10.5%) | $126.12 M(+0.9%) |
| June 2024 | - | $29.63 M(+10.9%) | $125.02 M(+4.1%) |
| Mar 2024 | - | $26.72 M(-38.2%) | $120.05 M(+2.8%) |
| Dec 2023 | $116.81 M(+33.0%) | $43.26 M(+70.2%) | $116.81 M(+21.4%) |
| Sept 2023 | - | $25.41 M(+3.1%) | $96.24 M(+3.9%) |
| June 2023 | - | $24.66 M(+5.0%) | $92.64 M(+0.6%) |
| Mar 2023 | - | $23.49 M(+3.6%) | $92.05 M(+4.8%) |
| Dec 2022 | $87.81 M(+53.4%) | $22.68 M(+4.0%) | $87.81 M(+5.9%) |
| Sept 2022 | - | $21.82 M(-9.3%) | $82.90 M(+7.9%) |
| June 2022 | - | $24.06 M(+25.0%) | $76.86 M(+16.1%) |
| Mar 2022 | - | $19.25 M(+8.3%) | $66.20 M(+15.7%) |
| Dec 2021 | $57.22 M | $17.77 M(+12.7%) | $57.22 M(+19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $15.77 M(+17.7%) | $47.80 M(+20.9%) |
| June 2021 | - | $13.40 M(+30.5%) | $39.53 M(+19.6%) |
| Mar 2021 | - | $10.27 M(+23.0%) | $33.07 M(+11.7%) |
| Dec 2020 | $29.61 M(+44.0%) | $8.35 M(+11.4%) | $29.61 M(+8.0%) |
| Sept 2020 | - | $7.50 M(+8.1%) | $27.41 M(+7.9%) |
| June 2020 | - | $6.94 M(+1.8%) | $25.40 M(+8.4%) |
| Mar 2020 | - | $6.81 M(+10.6%) | $23.44 M(+14.0%) |
| Dec 2019 | $20.55 M(+73.2%) | $6.16 M(+12.3%) | $20.55 M(+13.5%) |
| Sept 2019 | - | $5.49 M(+10.2%) | $18.10 M(+17.2%) |
| June 2019 | - | $4.98 M(+26.7%) | $15.45 M(+47.5%) |
| Mar 2019 | - | $3.93 M(+5.9%) | $10.47 M(+60.0%) |
| Dec 2018 | $11.87 M | $3.71 M(+30.9%) | $6.54 M(+130.9%) |
| Sept 2018 | - | $2.83 M | $2.83 M |
FAQ
- What is Beam Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Beam Therapeutics?
- What is Beam Therapeutics annual SG&A year-on-year change?
- What is Beam Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Beam Therapeutics?
- What is Beam Therapeutics quarterly SG&A year-on-year change?
- What is Beam Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Beam Therapeutics?
- What is Beam Therapeutics TTM SG&A year-on-year change?
What is Beam Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of BEAM is $116.81 M
What is the all time high annual SG&A for Beam Therapeutics?
Beam Therapeutics all-time high annual selling, general & administrative expenses is $116.81 M
What is Beam Therapeutics annual SG&A year-on-year change?
Over the past year, BEAM annual selling, general & administrative expenses has changed by +$29.01 M (+33.04%)
What is Beam Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of BEAM is $26.52 M
What is the all time high quarterly SG&A for Beam Therapeutics?
Beam Therapeutics all-time high quarterly selling, general & administrative expenses is $43.26 M
What is Beam Therapeutics quarterly SG&A year-on-year change?
Over the past year, BEAM quarterly selling, general & administrative expenses has changed by +$1.10 M (+4.35%)
What is Beam Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of BEAM is -$5.33 B
What is the all time high TTM SG&A for Beam Therapeutics?
Beam Therapeutics all-time high TTM selling, general & administrative expenses is $126.12 M
What is Beam Therapeutics TTM SG&A year-on-year change?
Over the past year, BEAM TTM selling, general & administrative expenses has changed by -$5.43 B (-5642.91%)